Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
3,840
Funds Holding Change
-52
Funds Holding Growth
-1%
Value
$1.09T
Holding in Top 10
1,410
Top 10 Change
+188
Top 10 Growth
+15%
Value Growth
-11%
New
139
Increased
1,732
Reduced
1,792
Closed
129
Capital Inflow
$46.1B
Capital Outflow
$42.7B
Net Capital Flow
+$3.37B
Capital Flow Change
-$34.1B
Calls
$13.4B
Puts
$13.5B
Net Calls
-$62.6M
Put/Call Ratio
1